Pharmaceutical Technology

MAY 2, 2023

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. This software-as-a-service (SaaS) platform is also used by life science brands to launch their drugs, therapeutics and vaccines in the markets, using data-driven solution.

Life Science 147

Life Science Branding Pharma Companies Sales 147

pharmaphorum

JANUARY 10, 2023

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. Capturing market share. The combination of health and data, he passionately believes, will transform life sciences. billion in 2021 to $9.23

Marketing 98

Marketing Life Science Sales Branding 98

pharmaphorum

SEPTEMBER 22, 2021

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. In the life sciences sector, the overall goal is to develop and commercialise innovative pharmaceutical solutions to improve health.

Pharma Companies 101

Pharma Companies Life Science Development Production 101

pharmaphorum

APRIL 19, 2022

Ehab graduated from Harvard Business school’s Executive General Management Programme in 2009 and holds a bachelor’s degree in Pharmaceutical Sciences. The post The largest pharma company in Europe calls for interoperability appeared first on. About the author .

Pharma Companies 99

Pharma Companies Life Science Clinical Research Research 99

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease. Multiple Sclerosis (MS).

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

VirTrial

SEPTEMBER 21, 2020

The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharma companies.?. 2020 Accolades. About Fierce Innovation Awards.

Life Science 52

Life Science Clinical Research Coordinator Pharma Companies Clinical Research 52

XTalks

OCTOBER 4, 2023

Health economics and outcomes research (HEOR) and market access strategies play a critical role in ensuring that newly approved therapies are made available to patients. Professionals in these roles are facing new challenges when it comes to negotiating coverage for many of the new, innovative treatments that are coming to market.

Marketing 105

Marketing Development Drugs Gene Therapy 105

Delveinsight

AUGUST 20, 2021

At present, there are several nonsurgical and surgical options in the Fecal Incontinence market. Conservative treatment approaches in the FI theraoy market include bulking agents and biofeedback. However, Biofeedback is the gold standard of the non-operative strategies in the FI therapeutics market.

Marketing 98

Marketing Pharma Companies Life Science Compliance 98

XTalks

MAY 20, 2021

In this episode, Ayesha discusses the latest trends in pharma tv ad spending, including the top spenders last week. The pandemic has led to a rise in both TV watching and health awareness, which pharma companies took advantage of by increasing spending on TV commercials by about 17 percent overall.

Life Science 52

Life Science Pharma Companies Development Drugs 52

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 106

Branding Marketing Pharma Companies Life Science 106

World of DTC Marketing

JANUARY 24, 2022

The amount of money required to gain approval of a new drug has been hotly debated, but it also costs a hell of a lot of money to launch a drug in today’s market. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3 Only about $2.2

Life Science 225

Life Science Drugs Genetic Disease Development 225

pharmaphorum

JANUARY 31, 2022

Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content. Pharma companies created 3.5 Veeva is the global leader in cloud software for the life sciences industry. Download the whitepaper here: [link].

Marketing 52

Marketing Life Science Compliance Pharma Companies 52

XTalks

FEBRUARY 17, 2021

Moreover, AI has the power to fuel a broad reach, extending out into local, national and international markets to harness data from user profiles worldwide. By leveraging AI technology, organizations can cut the time spent on advertising on job boards, social media and manually going through resumes and profiles online.

Life Science 97

Life Science HR Clinical Research Clinical Trials 97

Drug Discovery World

DECEMBER 6, 2023

The industry has responded that these sales rebate levels have damaged the UK’s international standing with global life science companies and are likely to continue to negatively impact UK life sciences and NHS patients’ access to medicines. in Spain and 8.25% in Ireland.

Life Science 59

Life Science Branding Medicine Pharma Companies 59

pharmaphorum

DECEMBER 14, 2022

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. November saw the launch of a new private equity team in life sciences at J.P. Morgan Asset Management, dubbed Life Sciences Private Capital. New CEO joins UBC.

Life Science 97

Life Science Gene Therapy Gene Editing Gene 97

pharmaphorum

JUNE 6, 2022

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. pic.twitter.com/MUKcXaganu. — Limitless Minds (@Thinkbig_gofar) July 25, 2019.

Sales 98

Sales Life Science Pharma Companies Marketing 98

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. Many new therapeutics are needed to treat the broad range of bacterial infections, and bringing new antibiotics to market is both difficult and expensive.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

pharmaphorum

JUNE 9, 2021

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment. Meet closerlook. The COVID-19 pandemic has highlighted the necessity of digital communication and the opportunities an omnichannel approach brings.

Marketing 54

Marketing Life Science Branding Production 54

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. And will be “highly damaging to UK life sciences and NHS patients’ access to medicines”.

Medicine 52

Medicine Life Science Branding Pharma Companies 52

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. The global wearable medical devices market size was valued at $73.77

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Within this, the progressive pharma companies are utilising modular content to increase brand standards.

Regulation 79

Regulation Marketing Sales Branding 79

pharmaphorum

AUGUST 18, 2020

Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted in pharma companies being more relevant and providing more value in closing the care gap, the report says.

Pharma Companies 128

Pharma Companies Sales Life Science Marketing 128

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals. We have 3,000 companies in the life sciences sector.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

pharmaphorum

NOVEMBER 3, 2021

Pharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content presented needs to stand out in the crowded digital space to garner attention. Content metrics is the collection of data related to an industry or a company’s content. New content does not need to be rewritten.

Pharma Companies 87

Pharma Companies Life Science Marketing Branding 87

pharmaphorum

DECEMBER 7, 2021

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them.

Life Science 95

Life Science Pharma Companies Branding Marketing 95

pharmaphorum

APRIL 19, 2022

In 2022, pharma is truly a global industry, and innovation can come from anywhere. But for small life sciences outside of the USA and Europe, it can still be challenging to break onto this global stage. The company recently raised $16.5 So] we are trying to go for the international market.”. “In

Marketing 52

Marketing Clinical Trials Clinical Trials Licensing 52

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 92

Life Science Pharma Companies Sales Marketing 92

pharmaphorum

JANUARY 21, 2021

86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a greater volume of content now, compared to six months ago. To assist executives in life sciences with scaling marketing assets in a virtual world Veeva has published a new eBook, Powering Omnichannel Strategies with Modular Content.

Life Science 59

Life Science Marketing Compliance Sales 59

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

Drug Discovery World

APRIL 27, 2023

Megan Thomas takes a snapshot of the US biotech market and some of the ongoing research coming out of the US. In 2021, Savills put together a report on the regional hubs attracting science/pharma investment 1. The Boston Globe headline 3 , ‘Life sciences is poised to be Boston’s dominant industry.

Life Science 52

Life Science Drugs Research Gene Splicing 52

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. .

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

Pharmaceutical Technology

OCTOBER 28, 2022

While implemented to improve transparency and market competition, this new legislation has caused considerable upheaval for clinical trial providers. But if they’re doing that internally, they may have a bias, either because of a life sciences background or involvement in the clinical trial itself.

Clinical Trials 130

Clinical Trials Clinical Trials Life Science Trials 130

Drug Discovery World

FEBRUARY 6, 2024

Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate. By making lab automation as easy as using a smartphone, the Flex robot democratises access to automation in life sciences research.”

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

OCTOBER 18, 2022

The group will work closely with another member, the Sustainable Health Coalition (SHC), in support of its work with the Sustainable Markets Initiative (SMI). The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. Growing pressure on life sciences.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form.

Life Science 67

Life Science Drugs Branding Medicine 67

Pharma Marketing Network

FEBRUARY 10, 2022

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Pharma marketers need to educate oncologists on available treatment options that keep up with the constant updates to standards of care. “In

Branding 98

Branding Marketing Life Science Pharma Companies 98

pharmaphorum

NOVEMBER 23, 2022

Innovative offerings around market access. A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My I’ve always worked as a consultant for pricing and access strategies for clients, helping them to get drugs to market and access patients.

Life Science 96

Life Science Marketing Medicine Production 96